Moderna, in addition to Pfizer and Johnson & Johnson, is conducting the third phase of clinical trials on experimental vaccines for the virus, during which tens of thousands of volunteers are injected with the vaccine, and a similar number to them with a placebo vaccine, in order to verify the effectiveness and safety of the vaccine.
There is a fourth vaccine in United State This reached the third stage, however Clinical trials It was temporarily suspended. It is a vaccine developed by AstraZeneca in cooperation with the University of Oxford.
And through the US President Donald Trump Several times, he hoped to find a vaccine before the November 3 elections, which raised fears among public health experts that “political pressure” would be put on the regulatory process to adopt VaccinesAccording to “Agence France Presse”.
Only Pfizer expects to achieve results by the end of October, days before the polling date, allowing the company to immediately file a license application from the Food and Drug Administration.
The testing protocol provides for a relatively rapid analysis of data, but scientists, statisticians in the field of biology and experts in clinical tests have warned of the dangers of granting accelerated approval, and preferred to test the vaccine for a few additional months, to ensure its effectiveness and possible side effects.
These were the details of the news The “Pfizer” vaccine precedes everyone to fulfill the “Trump promise” for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
